Piro, Geny
 Distribuzione geografica
Continente #
EU - Europa 1.909
NA - Nord America 1.497
AS - Asia 1.085
SA - Sud America 119
AF - Africa 22
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.639
Nazione #
US - Stati Uniti d'America 1.476
RU - Federazione Russa 731
CN - Cina 398
SG - Singapore 397
GB - Regno Unito 272
IT - Italia 241
DE - Germania 217
HK - Hong Kong 125
FI - Finlandia 119
SE - Svezia 93
BR - Brasile 91
IE - Irlanda 87
VN - Vietnam 75
FR - Francia 71
KR - Corea 22
NL - Olanda 16
UA - Ucraina 14
ID - Indonesia 13
AR - Argentina 12
JP - Giappone 12
AT - Austria 10
CA - Canada 10
ES - Italia 9
PL - Polonia 9
TR - Turchia 9
ZA - Sudafrica 8
BD - Bangladesh 6
IN - India 6
BE - Belgio 5
MX - Messico 5
BJ - Benin 4
CO - Colombia 4
PY - Paraguay 4
AU - Australia 3
EU - Europa 3
SA - Arabia Saudita 3
TG - Togo 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
EG - Egitto 2
GD - Grenada 2
IQ - Iraq 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
MA - Marocco 2
TW - Taiwan 2
UZ - Uzbekistan 2
VE - Venezuela 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
EE - Estonia 1
GI - Gibilterra 1
HN - Honduras 1
IR - Iran 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 4.639
Città #
Moscow 261
Chandler 245
Southend 241
Singapore 199
Dallas 197
Ashburn 180
Hong Kong 121
Munich 114
Verona 94
Beijing 89
Dublin 87
Helsinki 76
Woodbridge 71
Jacksonville 53
New York 39
Redmond 37
The Dalles 37
Jinan 33
Wilmington 28
Lawrence 26
Princeton 26
Los Angeles 23
Ann Arbor 21
Tianjin 21
Nanjing 19
Shenyang 19
Ho Chi Minh City 18
Hebei 17
Milan 17
Redondo Beach 16
Hanoi 15
Turku 15
São Paulo 13
Dong Ket 12
Haikou 12
Houston 12
Taiyuan 12
London 11
Tokyo 11
Buffalo 10
Jakarta 10
Nanchang 10
Redwood City 10
Sindelfingen 10
Atlanta 9
Zhengzhou 9
Columbus 8
Frankfurt am Main 8
Guangzhou 8
Jiaxing 8
Ningbo 8
Seattle 8
Warsaw 8
Changsha 7
Chicago 7
Denver 7
Lappeenranta 7
Montreal 7
Rome 7
Vienna 7
Boardman 6
Boston 6
Hangzhou 6
Johannesburg 6
Jyväskylä 6
Kent 6
San Francisco 6
Santa Clara 6
Washington 6
Brussels 5
Fairfield 5
Isola della Scala 5
Lanzhou 5
Nürnberg 5
Orem 5
Seoul 5
Stockholm 5
Amsterdam 4
Belo Horizonte 4
Biên Hòa 4
Bologna 4
Cotonou 4
Council Bluffs 4
Dearborn 4
Falkenstein 4
Falls Church 4
Haiphong 4
Lancaster 4
Phoenix 4
Taizhou 4
Ankara 3
Brasília 3
Brooklyn 3
Charlotte 3
Lomé 3
Madrid 3
Manchester 3
Mexico City 3
Modena 3
Mumbai 3
Totale 2.887
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 288
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 274
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 260
Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment 238
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 224
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 204
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 183
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 177
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis 168
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 166
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 166
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance 164
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 157
Plasma Interleukin-8 is a biomarker for TAK1 activation and predicts resistance to nanoliposomal irinotecan in patients with gemcitabine-refractory pancreatic cancer 157
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 151
Modulating TAK1 expression inhibits YAP and TAZ oncogenic functions in pancreatic cancer 147
Molecular alterations in basal cell carcinoma subtypes 138
Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy 136
MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity 131
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 125
Toll-Like Receptor 9 Agonists for Cancer Therapy 122
Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation 118
Local ablation disrupts immune evasion in pancreatic cancer 115
TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy 109
PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around 107
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer 88
Rationale and clinical use of multitargeting anticancer agents. 83
Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasis 71
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 69
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat 64
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer 64
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story 45
Totale 4.709
Categoria #
all - tutte 16.344
article - articoli 16.344
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.688


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021130 0 0 0 0 0 22 3 0 11 52 19 23
2021/2022281 31 92 12 15 7 5 3 19 6 8 15 68
2022/2023557 42 72 45 100 36 142 3 33 68 5 6 5
2023/2024375 9 16 29 41 37 66 25 52 6 32 43 19
2024/2025942 38 34 40 126 39 66 105 72 148 48 89 137
2025/20261.597 153 100 213 384 616 131 0 0 0 0 0 0
Totale 4.709